Recent Updates
Recently added Catalysts
CYAN

Dr. Gerald Cysewski, Chairman, President and CEO of Cyanotech Talks to The Wall Street Transcript Monday, December 6 NEW YORK (BUSINESS WIRE)

Key Takeaway: Dr. Gerald Cysewski, Chairman, President and CEO of Cyanotech Talks to The Wall Street Transcript NEW YORK (BUSINESS WIRE) Dec. 6, 2004 The Wall Street Transcript has published an in-depth interview with Dr. Gerald Cysewski, Chairman, President and CEO of Cyanotech in which

Full Press Release Details

Dr. Gerald Cysewski,
Chairman, President and CEO of Cyanotech Talks to The Wall Street Transcript
NEW YORK (BUSINESS WIRE) Dec. 6, 2004 The
Wall Street Transcript has published an in-depth interview with Dr. Gerald Cysewski,
Chairman, President and CEO of Cyanotech in
which he talks at length about the Company.
The entire 2,500 word interview is available
Cyanotech Corporation, a world leader in microalgal technology,
produces high-value natural products from microalgae and is the world s largest
commercial producer of natural astaxanthin (pronounced astazan- thin ) from
microalgae. Products include BioAstin natural astaxanthin, a powerful
antioxidant with expanding applications as a human nutraceutical; NatuRose
natural astaxanthin for the aquaculture and animal feed industries; Spirulina
Pacifica , a nutrient-rich dietary supplement; and phycobiliproteins, which are
fluorescent pigments used in the immunological diagnostics market. Spirulina
Pacifica and BioAstin are sold directly online through the Company s website,
www.nutrex-hawaii.com, as well as through resellers in over 30 countries
In describing the Company s product
development Dr. Cysewski states Microalgae represent the frontier of an
untapped natural resource and Cyanotech is pioneering the technology to tap
that resource. Not only is it possible to produce nutraceuticals and feed
supplements from microalgae, but we see a day when even pharmaceuticals could
be produced by microalgae. The implications are vast.
Regarding the market in which the company operates Dr. Cysewski states,
We re examining a number of other microalgae for potential new products and
applications. We see a market expanding to include such areas as personal care
products, cosmetics, suncare products, general health supplements and sports
In describing the Company s strategy Dr.
Cysewski states Our strategy for the next three years is first of all to focus
on business-to-business sales, working with large supplement and animal feed
companies in the US and throughout the world that will incorporate our high
quality products into their products.
The Wall Street Transcript does not endorse
the views of any interviewees nor does it make stock recommendations. For
subscription information call 800/246-7673.
Contact:
Corporation: Investors and Media:
Cyanotech Corporation Guerrant Associates
Jeffrey H. Sakamoto Laura Guerrant
(808) 326-1353 (808) 882-1467
jsakamoto@cyanotech.com lguerrant@guerrantir.com
Last updated: Dec 6, 2004